TERNS PHARMACEUTICALS INC (TERN)
US8808811074 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 121.89M | 46.14M | 120.20M | 14.50M | N/A | |||
| Cash Equivalents | 148.24M | 33.79M | 23.00M | 33.20M | 74.90M | |||
| Marketable Securities | 102.64M | 183.51M | 139.90M | 118.30M | 0.00 | |||
| Receivables | N/A | N/A | N/A | 0.00 | 12.70M | |||
| Other Current Assets | 3.73M | 3.99M | 2.10M | 900.00K | 3.30M | |||
| Total Current Assets | 376.51M | 267.43M | 285.20M | 166.90M | 90.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.67M | 1.03M | 1.80M | 1.00M | 1.20M | |||
| Other Non-Current Assets | 56.00K | 56.00K | 0.00 | 100.00K | 200.00K | |||
| Total Non-Current Assets | 1.73M | 1.08M | 1.80M | 1.20M | 1.40M | |||
| TOTAL ASSETS | 378.23M | 268.52M | 287.00M | 168.10M | 92.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 12.90M | |||
| Accrued Expenses | 9.15M | 9.15M | 6.60M | 4.30M | 8.80M | |||
| Accounts Payable | 1.79M | 2.52M | 1.60M | 2.10M | 900.00K | |||
| Other Current Liabilities | 477.00K | 278.00K | 200.00K | 400.00K | 200.00K | |||
| Total Current Liabilities | 11.41M | 11.94M | 8.50M | 6.80M | 22.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.35M | 1.21M | 1.60M | 900.00K | 900.00K | |||
| Total Non-Current Liabilities | 2.35M | 1.21M | 1.60M | 1.00M | 900.00K | |||
| TOTAL LIABILITIES | 13.76M | 13.15M | 10.10M | 7.80M | 23.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -399.68M | -332.63M | -242.40M | -182.10M | -131.90M | |||
| Additional Paid In Capital | 763.98M | 588.01M | 520.20M | 342.70M | 14.60M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 8.00K | 6.00K | 0.00 | 0.00 | 186.00M | |||
| Other Shareholders' Equity | 160.00K | -19.00K | -800.00K | -300.00K | -100.00K | |||
| Shares Outstanding | 84.92M | 64.58M | 53.70M | 25.30M | 22.70M | |||
| Tangible Book Value per Share | 4.29 | 3.95 | 5.16 | 6.34 | -5.17 | |||
| Total Shareholders' Equity | 364.47M | 255.37M | 276.90M | 160.30M | 68.60M | |||
| TOTAL LIABILITIES AND EQUITY | 378.23M | 268.52M | 287.00M | 168.10M | 92.30M | |||
| Statistics | ||||||||
| Current Ratio | 32.99 | 22.39 | 33.55 | 24.54 | 3.99 | |||
| Return On Assets (ROA) | -23.29% | -33.60% | -21.03% | -29.84% | -31.80% | |||
| Return On Equity (ROE) | -24.16% | -35.33% | -21.79% | -31.29% | -42.78% | |||
All data in USD , ROIC based on taxRate of 0.21